How have CELZ shares performed in 2024?

Creative Medical Technology's stock was trading at $4.61 on January 1st, 2024. Since then, CELZ stock has increased by 12.8% and is now trading at $5.20. View the best growth stocks for 2024 here .

Are investors shorting Creative Medical Technology?

Creative Medical Technology saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 28,700 shares, a decrease of 30.8% from the March 15th total of 41,500 shares. Based on an average daily trading volume, of 200,700 shares, the days-to-cover ratio is presently 0.1 days. Currently, 2.2% of the shares of the company are short sold. View Creative Medical Technology's Short Interest .

When is Creative Medical Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our CELZ earnings forecast .

How were Creative Medical Technology's earnings last quarter?

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its quarterly earnings results on Friday, March, 22nd. The company reported ($1.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.13) by $0.08.

When did Creative Medical Technology's stock split?

Creative Medical Technology shares reverse split on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Creative Medical Technology?

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free CELZ Stock Alerts

$5.20

-0.01 (-0.19%)

(As of 04/15/2024 ET)

Compare

Today's Range: $5.20
▼
$5.62
50-Day Range: $4.03
▼
$6.45
52-Week Range: $3.93
▼
$10.28

Volume: 7,851 shs
Average Volume: 181,474 shs
Market Capitalization: $7.07 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Creative Medical Technology alerts:

Creative Medical Technology MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
2.17% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.46
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($4.68) to ($3.77) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.07 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Creative Medical Technology.

5.0

Short Interest

Percentage of Shares Shorted
2.17% of the float of Creative Medical Technology has been sold short.
Short Interest Ratio / Days to Cover
Creative Medical Technology has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Creative Medical Technology has recently decreased by 30.84%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Creative Medical Technology does not currently pay a dividend.
Dividend Growth
Creative Medical Technology does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CELZ.

3.0

News and Social Media Coverage

News Sentiment
Creative Medical Technology has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Creative Medical Technology this week, compared to 0 articles on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Creative Medical Technology insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.30% of the stock of Creative Medical Technology is held by insiders.
Percentage Held by Institutions
Only 1.42% of the stock of Creative Medical Technology is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Creative Medical Technology are expected to grow in the coming year, from ($4.68) to ($3.77) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Creative Medical Technology is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Creative Medical Technology is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Creative Medical Technology has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About Creative Medical Technology Stock (NASDAQ:CELZ)

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CELZ Stock News Headlines

March 24, 2024 | finance.yahoo.com

Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

March 18, 2024 | forbes.com

Medical Practices And Branding In A Digital Age

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

March 18, 2024 | theglobeandmail.com

Creative Medical Technology Skyrockets on Word of New Diabetes Medication

March 7, 2024 | msn.com

Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?

March 7, 2024 | markets.businessinsider.com

Creative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock Up

March 7, 2024 | marketwatch.com

Creative Medical Shares Rise 37% After FDA Authorization for CELZ-201

March 7, 2024 | msn.com

Creative Medical stock rallies for second day on FDA updates

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

March 7, 2024 | finance.yahoo.com

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

March 6, 2024 | morningstar.com

Creative Medical Technology Holdings Inc

March 6, 2024 | markets.businessinsider.com

Creative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-market

March 6, 2024 | marketwatch.com

Creative Medical Shares Rally Premarket on FDA Orphan Designation

March 6, 2024 | msn.com

Creative Medical stock rallies 18% on FDA orphan drug designation

March 6, 2024 | businesswire.com

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

February 15, 2024 | investing.com

Creative Medical Technology Holdings Inc (CELZ)

February 9, 2024 | benzinga.com

Steven L White's Net Worth

December 20, 2023 | finance.yahoo.com

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

October 11, 2023 | msn.com

Creative Medical to initiate trial of lower back pain treatment

October 10, 2023 | markets.businessinsider.com

Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy

October 10, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

September 22, 2023 | finance.yahoo.com

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

September 19, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

August 24, 2023 | finance.yahoo.com

What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?

August 23, 2023 | benzinga.com

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?

June 28, 2023 | msn.com

Creative Medical Technology regains Nasdaq listing compliance

June 12, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Provides Corporate Update

See More Headlines

Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/22/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:CELZ
CUSIP: N/A
CIK: 1187953
Web: www.creativemedicaltechnology.com
Phone: (833) 336-7636
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,290,000.00
Net Margins: N/A
Pretax Margin: -58,744.45%
Return on Equity: -41.48%
Return on Assets: -40.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 27.68
Quick Ratio: 27.67

Sales & Book Value

Annual Sales: $10,000.00
Price / Sales: 726.24
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.48 per share
Price / Book: 0.71

Miscellaneous

Outstanding Shares: 1,360,000
Free Float: 1,312,000
Market Cap: $7.26 million
Optionable: Not Optionable
Beta: 2.20

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Timothy Warbington (Age 62)
Co-Founder, Chairman, President & CEO
Comp: $429k
Mr. Donald Dickerson (Age 59)
Senior VP, CFO & Director
Comp: $390k

Key Competitors

View All Competitors

Insiders

Timothy Warbington
Bought 800 shares on 6/27/2023
Total: $3,552.00 ($4.44/share)

View All Insider Transactions

CELZ Stock Analysis - Frequently Asked Questions

How have CELZ shares performed in 2024?: Creative Medical Technology's stock was trading at $4.61 on January 1st, 2024. Since then, CELZ stock has increased by 12.8% and is now trading at $5.20.
View the best growth stocks for 2024 here.
Are investors shorting Creative Medical Technology?: Creative Medical Technology saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 28,700 shares, a decrease of 30.8% from the March 15th total of 41,500 shares. Based on an average daily trading volume, of 200,700 shares, the days-to-cover ratio is presently 0.1 days. Currently, 2.2% of the shares of the company are short sold.
View Creative Medical Technology's Short Interest.
When is Creative Medical Technology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our CELZ earnings forecast.
How were Creative Medical Technology's earnings last quarter?: Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its quarterly earnings results on Friday, March, 22nd. The company reported ($1.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.13) by $0.08.

When did Creative Medical Technology's stock split?: Creative Medical Technology shares reverse split on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
How do I buy shares of Creative Medical Technology?: Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CELZ) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Creative Medical Technology (CELZ) Stock Price, News & Analysis

Creative Medical Technology MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Creative Medical Technology Stock (NASDAQ:CELZ)

CELZ Stock Price History

CELZ Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

CELZ Stock Analysis - Frequently Asked Questions

Overall MarketRank^™